v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (139,505) $ (115,563)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 11,954 8,308
Depreciation and amortization 9,646 10,783
Inventory write-down 298 1,569
Gain on sale of fixed asset disposal (90) 0
Write-off of right-of-use assets 70 0
Non-cash investment in Sky and Space 0 (1,706)
Change in fair value of equity investments 9,160 (4,852)
Change in fair value of liability classified warrants (15,862) 0
Change in fair value of convertible note (3,153) 0
Changes in operating assets and liabilities:    
Accounts receivable 103 2,035
Inventory (24,305) (24,345)
Prepaid expenses and other current assets (4,888) (5,267)
Deferred transaction costs 0 (230)
Other noncurrent assets 2,977 78
Due to related party, net (74) (83)
Accounts payable 9,391 5,127
Other long-term liabilities (966) (727)
Accrued liabilities 1,335 1,608
Deferred revenue (14,049) 11,681
Other, net (33) (110)
Net cash used in operating activities (157,991) (111,694)
Cash flows from investing activities:    
Purchase of property and equipment (17,115) (16,791)
Purchase of investment in Arqit 0 (5,000)
Proceeds from sale of property and equipment 90 0
Net cash used in investing activities (17,025) (21,791)
Cash flows from financing activities:    
Payments of finance lease obligations (227) (187)
Proceeds from the exercise of stock options 1,455 1,733
Advances to stock option holders 0 18
Parent Company contributions 0 137,141
Proceeds from convertible note 50,000 0
Net cash provided by financing activities 51,228 138,705
Net (decrease) increase in cash and cash equivalents and restricted cash (123,788) 5,220
Cash and cash equivalents and restricted cash at the beginning of the period 194,982 26,786
Cash and cash equivalents and restricted cash at the end of the period 71,194 32,006
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 71,194 31,178
Restricted cash 0 828
Cash and cash equivalents and restricted cash 71,194 32,006
Schedule for non-cash investing activities and financing activities    
Conversion of long-term debt due to Parent Company non-cash contributions 0 235,108
Deferred transaction costs in accounts payable and accrued liabilities 0 6,070
Unpaid property, plant and equipment received $ 78 $ 105

Source